INS and colorectal cancer: Dallas et al demonstrated that colorectal cancer cells that are resistant to 5-FU and oxaliplatin, by repeated exposure to drug, are more responsive to IGF-1R inhibition than the parental cells [35], suggesting that insulin signaling is deregulated during the process of acquiring drug resistance.